EBA's heath care committee holds drug policy seminar with Ukraine

6 November 2006

The health care committee of the European Business Association has organized a seminar alongside the EU-Ukraine summit on the theme: European Experience from Health Care Sector - Challenges and Solutions for Ukraine, which discussed, among other health care issues, various aspects of drug policy.

The October 26th seminar was hosted by the Finnish government in Helsinki, on the basis that Finland holds the rotating European Union presidency. Delegations from the Ukraine and the host country held three sessions, the last of which was about experiences of marketing authorization for generic drugs. The seminar's EU representatives stressed the importance to the Ukraine of information from the Pharmaceutical Pricing Board on "reasonable pricing" and the approval structure of reimbursible drugs according to different insurance systems.

A separate meeting was organized with Viktor Chumak, the Ukraine's Director of the State Pharmacological Center, and representatives of Finland's National Agency for Medicines to discuss market entry of drugs, planning drug services and consumer protection. Finland's experiences with the EU's data exclusivity mechanism were also discussed.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight